Under-utilization of statins among people with HIV who were aged 40 years or older

Wu, Pei-YingPei-YingWuHSIN-YUN SUNLuo, Yu-ZhenYu-ZhenLuoWANG-DA LIUChang, Hsi-YenHsi-YenChangYU-SHAN HUANGKUAN-YIN LINChen, Ling-YaLing-YaChenChen, Yi-TingYi-TingChenCHIEN-CHING HUNG2024-03-062024-03-062024-0216841182https://scholars.lib.ntu.edu.tw/handle/123456789/640388From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, ≥7.5 % to <20 % and ≥20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants met the criteria for statin therapy, but only 171 (38.8 %) were prescribed statins.enAtherosclerotic cardiovascular disease; Diabetes mellitus; Dyslipidemia; Lipid-lowering agent; Major adverse cardiovascular event; Non-communicable diseaseUnder-utilization of statins among people with HIV who were aged 40 years or olderjournal article10.1016/j.jmii.2024.01.003382332942-s2.0-85183758339https://api.elsevier.com/content/abstract/scopus_id/85183758339